

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 8.00643202 |
| 2 | sarcomere organization (GO:0045214) | 7.81657838 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.45192101 |
| 4 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.09433895 |
| 5 | myofibril assembly (GO:0030239) | 6.64280974 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.99603185 |
| 7 | cardiac muscle contraction (GO:0060048) | 5.91242370 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.79982840 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.79982840 |
| 10 | cardiac muscle cell development (GO:0055013) | 5.59446253 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.38693968 |
| 12 | regulation of actin filament-based movement (GO:1903115) | 5.35001383 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.32283211 |
| 14 | cardiac cell development (GO:0055006) | 5.28683721 |
| 15 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.24374700 |
| 16 | plasma membrane repair (GO:0001778) | 5.23848910 |
| 17 | adult heart development (GO:0007512) | 5.23257707 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16127687 |
| 19 | actin-myosin filament sliding (GO:0033275) | 5.15143290 |
| 20 | muscle filament sliding (GO:0030049) | 5.15143290 |
| 21 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.12964252 |
| 22 | actomyosin structure organization (GO:0031032) | 5.09958775 |
| 23 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.07264937 |
| 24 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.05422839 |
| 25 | heart trabecula formation (GO:0060347) | 4.99347505 |
| 26 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.95633116 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.89009961 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 4.87662525 |
| 29 | regulation of sarcomere organization (GO:0060297) | 4.81829650 |
| 30 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.81694181 |
| 31 | cardiac muscle hypertrophy (GO:0003300) | 4.80241421 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.80050802 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79246476 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.76159408 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.70660968 |
| 36 | negative T cell selection (GO:0043383) | 4.59165753 |
| 37 | regulation of the force of heart contraction (GO:0002026) | 4.54284306 |
| 38 | striated muscle hypertrophy (GO:0014897) | 4.51548396 |
| 39 | tricarboxylic acid cycle (GO:0006099) | 4.46845226 |
| 40 | negative thymic T cell selection (GO:0045060) | 4.43502362 |
| 41 | cell communication involved in cardiac conduction (GO:0086065) | 4.40046385 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 4.34893462 |
| 43 | actin-mediated cell contraction (GO:0070252) | 4.30741634 |
| 44 | cell communication by electrical coupling (GO:0010644) | 4.29912648 |
| 45 | response to interleukin-15 (GO:0070672) | 4.28175663 |
| 46 | muscle tissue morphogenesis (GO:0060415) | 4.27293585 |
| 47 | positive T cell selection (GO:0043368) | 4.26946035 |
| 48 | striated muscle contraction (GO:0006941) | 4.17861904 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 4.17684157 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.14646113 |
| 51 | regulation of cardioblast differentiation (GO:0051890) | 4.14560059 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.10257129 |
| 53 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.08099378 |
| 54 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.07784847 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.00051775 |
| 56 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.99968200 |
| 57 | muscle hypertrophy (GO:0014896) | 3.97520015 |
| 58 | thymic T cell selection (GO:0045061) | 3.94471034 |
| 59 | relaxation of cardiac muscle (GO:0055119) | 3.91832928 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 3.86655371 |
| 61 | regulation of cardiac muscle contraction (GO:0055117) | 3.83709815 |
| 62 | leukocyte aggregation (GO:0070486) | 3.83236983 |
| 63 | negative regulation of potassium ion transport (GO:0043267) | 3.82816074 |
| 64 | activated T cell proliferation (GO:0050798) | 3.80066208 |
| 65 | cardiac muscle adaptation (GO:0014887) | 3.79359199 |
| 66 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.79359199 |
| 67 | muscle hypertrophy in response to stress (GO:0003299) | 3.79359199 |
| 68 | T cell selection (GO:0045058) | 3.75096519 |
| 69 | carnitine shuttle (GO:0006853) | 3.74270877 |
| 70 | regulation of cell communication by electrical coupling (GO:0010649) | 3.72969698 |
| 71 | actin filament-based movement (GO:0030048) | 3.65033289 |
| 72 | regulation of skeletal muscle contraction (GO:0014819) | 3.62544451 |
| 73 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.61807896 |
| 74 | atrial septum morphogenesis (GO:0060413) | 3.58701816 |
| 75 | regulation of heart rate (GO:0002027) | 3.54682127 |
| 76 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.49427985 |
| 77 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.48644423 |
| 78 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47401217 |
| 79 | potassium ion export (GO:0071435) | 3.46341952 |
| 80 | trabecula formation (GO:0060343) | 3.42466703 |
| 81 | heart process (GO:0003015) | 3.40693774 |
| 82 | heart contraction (GO:0060047) | 3.40693774 |
| 83 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.40391069 |
| 84 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.38154085 |
| 85 | venous blood vessel morphogenesis (GO:0048845) | 3.37625568 |
| 86 | regulation of heart contraction (GO:0008016) | 3.37132636 |
| 87 | cardiac muscle cell action potential (GO:0086001) | 3.33853477 |
| 88 | ventricular cardiac muscle cell development (GO:0055015) | 3.33823230 |
| 89 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.26859392 |
| 90 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.26859392 |
| 91 | cardiac chamber formation (GO:0003207) | 3.26451506 |
| 92 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25769220 |
| 93 | positive regulation of tolerance induction (GO:0002645) | 3.25018453 |
| 94 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.23957421 |
| 95 | cardiac conduction (GO:0061337) | 3.23621307 |
| 96 | regulation of regulatory T cell differentiation (GO:0045589) | 3.22923436 |
| 97 | regulation of tolerance induction (GO:0002643) | 3.21793759 |
| 98 | tolerance induction (GO:0002507) | 3.20261698 |
| 99 | T cell migration (GO:0072678) | 3.18987435 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.18882000 |
| 101 | blood vessel maturation (GO:0001955) | 3.16687924 |
| 102 | cell migration involved in heart development (GO:0060973) | 3.15820909 |
| 103 | regulation of ATP catabolic process (GO:1903289) | 3.14728103 |
| 104 | regulation of ATPase activity (GO:0043462) | 3.14728103 |
| 105 | B cell receptor signaling pathway (GO:0050853) | 3.13367582 |
| 106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12306332 |
| 107 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.11890936 |
| 108 | fatty acid transmembrane transport (GO:1902001) | 3.11619612 |
| 109 | negative regulation of cell size (GO:0045792) | 3.10766998 |
| 110 | membrane repolarization during action potential (GO:0086011) | 3.09822636 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.07698615 |
| 112 | positive thymic T cell selection (GO:0045059) | 3.07307220 |
| 113 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.05712594 |
| 114 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.05246892 |
| 115 | negative regulation of heart growth (GO:0061117) | 3.05246892 |
| 116 | NIK/NF-kappaB signaling (GO:0038061) | 3.04596239 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02520955 |
| 118 | oxygen transport (GO:0015671) | 3.01655218 |
| 119 | positive regulation of heart contraction (GO:0045823) | 3.00999250 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00590222 |
| 121 | regulation of muscle contraction (GO:0006937) | 2.98165964 |
| 122 | positive regulation of cation channel activity (GO:2001259) | 2.97666074 |
| 123 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.96860851 |
| 124 | cardiac muscle cell proliferation (GO:0060038) | 2.96321407 |
| 125 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95343857 |
| 126 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94702220 |
| 127 | regulation of B cell differentiation (GO:0045577) | 2.94654096 |
| 128 | striated muscle cell development (GO:0055002) | 2.93571404 |
| 129 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.91909233 |
| 130 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.90913407 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89321607 |
| 132 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.88317667 |
| 133 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.88099220 |
| 134 | negative regulation of protein localization to cell surface (GO:2000009) | 2.87599479 |
| 135 | outflow tract septum morphogenesis (GO:0003148) | 2.86102791 |
| 136 | regulation of tight junction assembly (GO:2000810) | 2.83812718 |
| 137 | epithelial cell-cell adhesion (GO:0090136) | 2.82270633 |
| 138 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.81611086 |
| 139 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.81611086 |
| 140 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.81537698 |
| 141 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.81537698 |
| 142 | regulation of extracellular matrix disassembly (GO:0010715) | 2.81214946 |
| 143 | T cell receptor signaling pathway (GO:0050852) | 2.80824617 |
| 144 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.78166265 |
| 145 | growth hormone secretion (GO:0030252) | 2.77817572 |
| 146 | striated muscle adaptation (GO:0014888) | 2.77734713 |
| 147 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.76825123 |
| 148 | type B pancreatic cell proliferation (GO:0044342) | 2.75656568 |
| 149 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.75556621 |
| 150 | negative regulation of phagocytosis (GO:0050765) | 2.75012334 |
| 151 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.74974142 |
| 152 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.74495101 |
| 153 | detection of bacterium (GO:0016045) | 2.73158108 |
| 154 | regulation of cofactor metabolic process (GO:0051193) | 2.72986622 |
| 155 | pericardium development (GO:0060039) | 2.72632293 |
| 156 | lymph node development (GO:0048535) | 2.72277344 |
| 157 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70546320 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.69101060 |
| 159 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67209387 |
| 160 | modulation by symbiont of host defense response (GO:0052031) | 2.67209387 |
| 161 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67209387 |
| 162 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67209387 |
| 163 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67209387 |
| 164 | modulation by symbiont of host immune response (GO:0052553) | 2.67209387 |
| 165 | negative regulation of type 2 immune response (GO:0002829) | 2.66260383 |
| 166 | atrioventricular valve morphogenesis (GO:0003181) | 2.64532022 |
| 167 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.64316705 |
| 168 | response to laminar fluid shear stress (GO:0034616) | 2.64268768 |
| 169 | detection of other organism (GO:0098543) | 2.63285659 |
| 170 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.61568574 |
| 171 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.59912186 |
| 172 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.59654721 |
| 173 | bone trabecula formation (GO:0060346) | 2.58863406 |
| 174 | extracellular matrix assembly (GO:0085029) | 2.57946298 |
| 175 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57399144 |
| 176 | type I interferon signaling pathway (GO:0060337) | 2.56601903 |
| 177 | cellular response to type I interferon (GO:0071357) | 2.56601903 |
| 178 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.55901226 |
| 179 | response to type I interferon (GO:0034340) | 2.54661805 |
| 180 | T cell homeostasis (GO:0043029) | 2.53903384 |
| 181 | cellular extravasation (GO:0045123) | 2.52195479 |
| 182 | protein heterotrimerization (GO:0070208) | 2.48560341 |
| 183 | interferon-gamma production (GO:0032609) | 2.48524062 |
| 184 | positive regulation of cell killing (GO:0031343) | 2.45394797 |
| 185 | regulation of cell killing (GO:0031341) | 2.42957759 |
| 186 | positive regulation of fibroblast migration (GO:0010763) | 2.42302994 |
| 187 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.40097918 |
| 188 | T cell costimulation (GO:0031295) | 2.39520987 |
| 189 | positive regulation of B cell differentiation (GO:0045579) | 2.38768672 |
| 190 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.37966688 |
| 191 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.36782306 |
| 192 | fibril organization (GO:0097435) | 2.36463316 |
| 193 | lymphocyte costimulation (GO:0031294) | 2.36302395 |
| 194 | regulation of defense response to virus by virus (GO:0050690) | 2.32240193 |
| 195 | negative regulation of bone remodeling (GO:0046851) | 2.31681721 |
| 196 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.31649738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.56078403 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.37080629 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25348353 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.22894207 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.22894207 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.19438915 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.11466737 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.97677364 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.65880407 |
| 10 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.62131662 |
| 11 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.51701412 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.48691131 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48552200 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.42440185 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39692499 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26601890 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.25067812 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.25021469 |
| 19 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.17679129 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.14148087 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13933601 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11451851 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06367972 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.96906378 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.94378908 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92156264 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90289792 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89112677 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88657403 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87422722 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.81607512 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79027589 |
| 33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74384460 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.72211525 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71275597 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68533184 |
| 37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67781994 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66605445 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64046342 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63530383 |
| 41 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63106978 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.62758150 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62751000 |
| 44 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.60344283 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58917796 |
| 46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58598538 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58224018 |
| 48 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.57250847 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56409983 |
| 50 | * MYB_26560356_Chip-Seq_TH1_Human | 1.55651629 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55316839 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55237086 |
| 53 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.54399865 |
| 54 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51503541 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49281242 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48610508 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44187106 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.42425566 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.41856883 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41123365 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40889872 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40595127 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39558406 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38931624 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38901290 |
| 66 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.38379851 |
| 67 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.36796909 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36357872 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.35488263 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34693549 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34154978 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34071611 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33280062 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30983658 |
| 75 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.30726637 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30292701 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29919780 |
| 78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29883052 |
| 79 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29331115 |
| 80 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.26827992 |
| 81 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25011560 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21675956 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20942448 |
| 84 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20080850 |
| 85 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.20002590 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17376786 |
| 87 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.17083378 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16192729 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14523572 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13174341 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13061873 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12575107 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12209204 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11879013 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11245159 |
| 96 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09239350 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.08887689 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08748918 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08361653 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06456845 |
| 101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06033313 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04961440 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04399035 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02929477 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02888062 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02597247 |
| 107 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01771728 |
| 108 | * MYB_26560356_Chip-Seq_TH2_Human | 1.01364573 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01349708 |
| 110 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99637712 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99379411 |
| 112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99270129 |
| 113 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98423239 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98096949 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97911055 |
| 116 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.97876497 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97817668 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97370179 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97278544 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96632661 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96332233 |
| 122 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.95714892 |
| 123 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95169262 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95112805 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94347653 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93786079 |
| 127 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92262044 |
| 128 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91961812 |
| 129 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.91039473 |
| 130 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90998585 |
| 131 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90865706 |
| 132 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90009108 |
| 133 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89496084 |
| 134 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87907641 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87309583 |
| 136 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87173248 |
| 137 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85822924 |
| 138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85747829 |
| 139 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85233972 |
| 140 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83723332 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83710590 |
| 142 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80696997 |
| 143 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79402435 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77985974 |
| 145 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.76205751 |
| 146 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.76140878 |
| 147 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.75529985 |
| 148 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75432168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.03571030 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.77994091 |
| 3 | MP0000751_myopathy | 4.36368230 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.33977916 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.96798608 |
| 6 | MP0005330_cardiomyopathy | 3.69623955 |
| 7 | MP0003646_muscle_fatigue | 3.63914945 |
| 8 | MP0002972_abnormal_cardiac_muscle | 3.06039671 |
| 9 | MP0008775_abnormal_heart_ventricle | 2.91636343 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.84392883 |
| 11 | MP0003137_abnormal_impulse_conducting | 2.78883247 |
| 12 | MP0000749_muscle_degeneration | 2.74725683 |
| 13 | MP0010630_abnormal_cardiac_muscle | 2.74311697 |
| 14 | MP0003436_decreased_susceptibility_to | 2.70001975 |
| 15 | MP0003828_pulmonary_edema | 2.68958048 |
| 16 | MP0003724_increased_susceptibility_to | 2.61898645 |
| 17 | MP0001544_abnormal_cardiovascular_syste | 2.61040647 |
| 18 | MP0005385_cardiovascular_system_phenoty | 2.61040647 |
| 19 | MP0005671_abnormal_response_to | 2.53065247 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.47825869 |
| 21 | MP0006138_congestive_heart_failure | 2.44173607 |
| 22 | MP0005620_abnormal_muscle_contractility | 2.35295937 |
| 23 | MP0004510_myositis | 2.27713618 |
| 24 | MP0003279_aneurysm | 2.22481329 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.21123353 |
| 26 | MP0004484_altered_response_of | 2.17432923 |
| 27 | MP0004130_abnormal_muscle_cell | 2.15638886 |
| 28 | MP0001800_abnormal_humoral_immune | 2.12819548 |
| 29 | MP0001542_abnormal_bone_strength | 2.12647066 |
| 30 | MP0004085_abnormal_heartbeat | 2.10016979 |
| 31 | MP0002106_abnormal_muscle_physiology | 2.07379639 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.91853589 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.87755965 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.78142194 |
| 35 | MP0001819_abnormal_immune_cell | 1.73895092 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.72586203 |
| 37 | MP0002723_abnormal_immune_serum | 1.71625871 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.71010033 |
| 39 | MP0005025_abnormal_response_to | 1.68830152 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.68527353 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.66302593 |
| 42 | MP0005369_muscle_phenotype | 1.65472632 |
| 43 | MP0000759_abnormal_skeletal_muscle | 1.65371026 |
| 44 | MP0004233_abnormal_muscle_weight | 1.63901818 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.63764343 |
| 46 | MP0002269_muscular_atrophy | 1.63168837 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.62628772 |
| 48 | MP0006082_CNS_inflammation | 1.62347819 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.62159060 |
| 50 | MP0002405_respiratory_system_inflammati | 1.62008489 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 1.58640876 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.56317640 |
| 53 | MP0002419_abnormal_innate_immunity | 1.53659848 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.53005882 |
| 55 | MP0009785_altered_susceptibility_to | 1.49364348 |
| 56 | MP0000747_muscle_weakness | 1.48399515 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.46962462 |
| 58 | MP0002398_abnormal_bone_marrow | 1.44845552 |
| 59 | MP0003866_abnormal_defecation | 1.44710028 |
| 60 | MP0002295_abnormal_pulmonary_circulatio | 1.41749046 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.39415237 |
| 62 | MP0000716_abnormal_immune_system | 1.36994439 |
| 63 | MP0004883_abnormal_blood_vessel | 1.34070532 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.31614041 |
| 65 | MP0000266_abnormal_heart_morphology | 1.31308789 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.26925374 |
| 67 | MP0004272_abnormal_basement_membrane | 1.26672693 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 1.25761077 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.25091011 |
| 70 | MP0002234_abnormal_pharynx_morphology | 1.24939359 |
| 71 | MP0005390_skeleton_phenotype | 1.22630114 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.20638562 |
| 73 | MP0003448_altered_tumor_morphology | 1.20445546 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.20222583 |
| 75 | MP0009384_cardiac_valve_regurgitation | 1.18621643 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.18171639 |
| 77 | MP0002722_abnormal_immune_system | 1.16173076 |
| 78 | MP0005165_increased_susceptibility_to | 1.15950038 |
| 79 | MP0000689_abnormal_spleen_morphology | 1.15697381 |
| 80 | MP0001958_emphysema | 1.14344396 |
| 81 | MP0000858_altered_metastatic_potential | 1.12368219 |
| 82 | MP0002128_abnormal_blood_circulation | 1.11938260 |
| 83 | MP0000733_abnormal_muscle_development | 1.11024800 |
| 84 | MP0003300_gastrointestinal_ulcer | 1.09401551 |
| 85 | MP0005164_abnormal_response_to | 1.08731903 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.08210713 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.07847053 |
| 88 | MP0004947_skin_inflammation | 1.07074703 |
| 89 | MP0008961_abnormal_basal_metabolism | 1.07027818 |
| 90 | MP0005275_abnormal_skin_tensile | 1.06116116 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 1.05653619 |
| 92 | MP0005375_adipose_tissue_phenotype | 1.04144070 |
| 93 | MP0001873_stomach_inflammation | 1.02510443 |
| 94 | MP0002429_abnormal_blood_cell | 1.02194878 |
| 95 | MP0006054_spinal_hemorrhage | 1.01662131 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 1.01431687 |
| 97 | MP0000013_abnormal_adipose_tissue | 1.00345739 |
| 98 | MP0008260_abnormal_autophagy | 0.99111404 |
| 99 | MP0000343_altered_response_to | 0.99073628 |
| 100 | MP0001851_eye_inflammation | 0.98388414 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.97671480 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.92834344 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.92092076 |
| 104 | MP0002148_abnormal_hypersensitivity_rea | 0.90456368 |
| 105 | MP0001243_abnormal_dermal_layer | 0.88976063 |
| 106 | MP0005670_abnormal_white_adipose | 0.88236761 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.87076507 |
| 108 | MP0005508_abnormal_skeleton_morphology | 0.86721868 |
| 109 | MP0005464_abnormal_platelet_physiology | 0.86234787 |
| 110 | MP0005503_abnormal_tendon_morphology | 0.85395511 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.83561215 |
| 112 | MP0003303_peritoneal_inflammation | 0.83144855 |
| 113 | MP0002925_abnormal_cardiovascular_devel | 0.82907090 |
| 114 | MP0003045_fibrosis | 0.81644068 |
| 115 | MP0003091_abnormal_cell_migration | 0.81147840 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.79627740 |
| 117 | MP0003795_abnormal_bone_structure | 0.77861837 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.74909856 |
| 119 | MP0006036_abnormal_mitochondrial_physio | 0.73044106 |
| 120 | MP0002132_abnormal_respiratory_system | 0.70195555 |
| 121 | MP0001784_abnormal_fluid_regulation | 0.69046113 |
| 122 | MP0001663_abnormal_digestive_system | 0.68568370 |
| 123 | MP0001175_abnormal_lung_morphology | 0.66746382 |
| 124 | MP0002254_reproductive_system_inflammat | 0.66408121 |
| 125 | MP0002108_abnormal_muscle_morphology | 0.65298191 |
| 126 | MP0002168_other_aberrant_phenotype | 0.64701537 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.64100735 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.63925300 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.63548861 |
| 130 | MP0003763_abnormal_thymus_physiology | 0.62717793 |
| 131 | MP0001614_abnormal_blood_vessel | 0.62200407 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.60938315 |
| 133 | MP0002933_joint_inflammation | 0.56129677 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.55100587 |
| 135 | MP0004808_abnormal_hematopoietic_stem | 0.51577330 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.50800423 |
| 137 | MP0005377_hearing/vestibular/ear_phenot | 0.49449720 |
| 138 | MP0003878_abnormal_ear_physiology | 0.49449720 |
| 139 | MP0003984_embryonic_growth_retardation | 0.49035080 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.48530503 |
| 141 | MP0000428_abnormal_craniofacial_morphol | 0.48040867 |
| 142 | MP0002896_abnormal_bone_mineralization | 0.46232262 |
| 143 | MP0003385_abnormal_body_wall | 0.44951410 |
| 144 | MP0005187_abnormal_penis_morphology | 0.43586534 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.38550580 |
| 146 | MP0005023_abnormal_wound_healing | 0.38284501 |
| 147 | MP0000249_abnormal_blood_vessel | 0.37940885 |
| 148 | MP0002133_abnormal_respiratory_system | 0.37470545 |
| 149 | MP0005388_respiratory_system_phenotype | 0.37470545 |
| 150 | MP0003935_abnormal_craniofacial_develop | 0.37044575 |
| 151 | MP0009278_abnormal_bone_marrow | 0.36520116 |
| 152 | MP0000685_abnormal_immune_system | 0.35458365 |
| 153 | MP0005387_immune_system_phenotype | 0.35409469 |
| 154 | MP0001790_abnormal_immune_system | 0.35409469 |
| 155 | MP0003115_abnormal_respiratory_system | 0.34894348 |
| 156 | MP0003948_abnormal_gas_homeostasis | 0.34028892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.05861902 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.63977623 |
| 3 | Atrial fibrillation (HP:0005110) | 5.98402316 |
| 4 | Subaortic stenosis (HP:0001682) | 5.74509238 |
| 5 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.74509238 |
| 6 | Primary atrial arrhythmia (HP:0001692) | 5.63945271 |
| 7 | Supraventricular tachycardia (HP:0004755) | 5.43215408 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 5.38015684 |
| 9 | Lipoatrophy (HP:0100578) | 5.17475198 |
| 10 | Syncope (HP:0001279) | 4.94919481 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 4.91061907 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.65690436 |
| 13 | Prolonged QT interval (HP:0001657) | 4.63792264 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 4.60322461 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.53640464 |
| 16 | Asymmetric septal hypertrophy (HP:0001670) | 4.42307442 |
| 17 | Bundle branch block (HP:0011710) | 4.32138467 |
| 18 | Ventricular fibrillation (HP:0001663) | 4.32052750 |
| 19 | Vascular tortuosity (HP:0004948) | 4.28493704 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 4.22726678 |
| 21 | Ventricular arrhythmia (HP:0004308) | 4.18653702 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 4.18552040 |
| 23 | Dilated cardiomyopathy (HP:0001644) | 4.13038739 |
| 24 | Exercise-induced myalgia (HP:0003738) | 4.04210194 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.98618086 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.92861341 |
| 27 | Palpitations (HP:0001962) | 3.82949381 |
| 28 | Dilatation of the ascending aorta (HP:0005111) | 3.80560630 |
| 29 | Peritonitis (HP:0002586) | 3.80024115 |
| 30 | Arterial tortuosity (HP:0005116) | 3.74675134 |
| 31 | Atrioventricular block (HP:0001678) | 3.74048077 |
| 32 | T lymphocytopenia (HP:0005403) | 3.73225568 |
| 33 | Heart block (HP:0012722) | 3.54458908 |
| 34 | Myoglobinuria (HP:0002913) | 3.48941785 |
| 35 | EMG: myopathic abnormalities (HP:0003458) | 3.46435144 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.43175517 |
| 37 | Abnormal atrioventricular conduction (HP:0005150) | 3.40373417 |
| 38 | Increased connective tissue (HP:0009025) | 3.34844234 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32408861 |
| 40 | Abnormal EKG (HP:0003115) | 3.25579346 |
| 41 | Spondylolisthesis (HP:0003302) | 3.14611921 |
| 42 | Spontaneous hematomas (HP:0007420) | 3.11865919 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.02082553 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96099251 |
| 45 | Soft skin (HP:0000977) | 2.94546356 |
| 46 | Broad metatarsal (HP:0001783) | 2.92685329 |
| 47 | Myositis (HP:0100614) | 2.90245647 |
| 48 | Difficulty running (HP:0009046) | 2.80621371 |
| 49 | Sudden cardiac death (HP:0001645) | 2.73439647 |
| 50 | Emphysema (HP:0002097) | 2.73317982 |
| 51 | Mitral valve prolapse (HP:0001634) | 2.73310507 |
| 52 | Myotonia (HP:0002486) | 2.71467603 |
| 53 | Protrusio acetabuli (HP:0003179) | 2.65126629 |
| 54 | Cervical subluxation (HP:0003308) | 2.63040344 |
| 55 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.56268355 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.56164519 |
| 57 | Left ventricular hypertrophy (HP:0001712) | 2.54229863 |
| 58 | Slender build (HP:0001533) | 2.54038840 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.53367362 |
| 60 | Stomatitis (HP:0010280) | 2.53301493 |
| 61 | Wormian bones (HP:0002645) | 2.51265929 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.49867302 |
| 63 | Pustule (HP:0200039) | 2.49124829 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.48951714 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.48621696 |
| 66 | Genu recurvatum (HP:0002816) | 2.46653536 |
| 67 | Type 1 muscle fiber predominance (HP:0003803) | 2.45399365 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.43494092 |
| 69 | Recurrent fungal infections (HP:0002841) | 2.39953378 |
| 70 | Cellulitis (HP:0100658) | 2.39218120 |
| 71 | Lymphangioma (HP:0100764) | 2.37193273 |
| 72 | Conjunctival hamartoma (HP:0100780) | 2.37170283 |
| 73 | Atrophic scars (HP:0001075) | 2.35612414 |
| 74 | Rhabdomyolysis (HP:0003201) | 2.35230749 |
| 75 | Orchitis (HP:0100796) | 2.32631373 |
| 76 | Leukocytosis (HP:0001974) | 2.30950300 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.30457334 |
| 78 | Abnormality of T cells (HP:0002843) | 2.27579743 |
| 79 | Follicular hyperkeratosis (HP:0007502) | 2.25406383 |
| 80 | Palmoplantar keratoderma (HP:0000982) | 2.23959386 |
| 81 | Fragile skin (HP:0001030) | 2.23905528 |
| 82 | Limb-girdle muscle atrophy (HP:0003797) | 2.22508248 |
| 83 | Meningitis (HP:0001287) | 2.21553809 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.21220700 |
| 85 | Persistence of primary teeth (HP:0006335) | 2.21044509 |
| 86 | Ankle contracture (HP:0006466) | 2.20437075 |
| 87 | Premature rupture of membranes (HP:0001788) | 2.20404914 |
| 88 | Mitral regurgitation (HP:0001653) | 2.19587789 |
| 89 | Vasculitis (HP:0002633) | 2.18832679 |
| 90 | Scapular winging (HP:0003691) | 2.18816070 |
| 91 | Blue sclerae (HP:0000592) | 2.18350017 |
| 92 | Joint laxity (HP:0001388) | 2.17752355 |
| 93 | Lymphopenia (HP:0001888) | 2.16955457 |
| 94 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16870089 |
| 95 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16870089 |
| 96 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.16175772 |
| 97 | Recurrent bacterial skin infections (HP:0005406) | 2.14505920 |
| 98 | Disproportionate tall stature (HP:0001519) | 2.13784476 |
| 99 | Aortic valve stenosis (HP:0001650) | 2.13580758 |
| 100 | Hypoventilation (HP:0002791) | 2.12502708 |
| 101 | Nonimmune hydrops fetalis (HP:0001790) | 2.11724019 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.10478812 |
| 103 | Aortic regurgitation (HP:0001659) | 2.09921703 |
| 104 | Congestive heart failure (HP:0001635) | 2.09228976 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 2.09214009 |
| 106 | Abnormality of the tricuspid valve (HP:0001702) | 2.09023238 |
| 107 | Increased IgE level (HP:0003212) | 2.08229948 |
| 108 | Aneurysm (HP:0002617) | 2.05205288 |
| 109 | Large for gestational age (HP:0001520) | 2.04505481 |
| 110 | Hypoglycemic coma (HP:0001325) | 2.04113512 |
| 111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03990836 |
| 112 | Gingivitis (HP:0000230) | 2.02001682 |
| 113 | Broad ribs (HP:0000885) | 2.01876313 |
| 114 | Abnormality of the peritoneum (HP:0002585) | 2.01459253 |
| 115 | Hamartoma of the eye (HP:0010568) | 2.00963985 |
| 116 | Ketoacidosis (HP:0001993) | 1.99461156 |
| 117 | Retrobulbar optic neuritis (HP:0100654) | 1.99281195 |
| 118 | Optic neuritis (HP:0100653) | 1.99281195 |
| 119 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98974885 |
| 120 | Striae distensae (HP:0001065) | 1.97645602 |
| 121 | Joint stiffness (HP:0001387) | 1.97442552 |
| 122 | Vertebral compression fractures (HP:0002953) | 1.97426105 |
| 123 | Biconcave vertebral bodies (HP:0004586) | 1.96633722 |
| 124 | Ectopia lentis (HP:0001083) | 1.96369285 |
| 125 | Dysmetric saccades (HP:0000641) | 1.96215797 |
| 126 | Hypoplastic ischia (HP:0003175) | 1.94186497 |
| 127 | Pulmonary artery stenosis (HP:0004415) | 1.93739767 |
| 128 | Chest pain (HP:0100749) | 1.93453653 |
| 129 | Hypergammaglobulinemia (HP:0010702) | 1.93261398 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.92576794 |
| 131 | Increased IgM level (HP:0003496) | 1.92028022 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.91410973 |
| 133 | Abnormality of dentin (HP:0010299) | 1.88981573 |
| 134 | Microcytic anemia (HP:0001935) | 1.88919237 |
| 135 | Recurrent viral infections (HP:0004429) | 1.88485583 |
| 136 | Aortic aneurysm (HP:0004942) | 1.85112162 |
| 137 | Panhypogammaglobulinemia (HP:0003139) | 1.85031407 |
| 138 | Abnormality of eosinophils (HP:0001879) | 1.84997416 |
| 139 | Encephalitis (HP:0002383) | 1.84896766 |
| 140 | Wide anterior fontanel (HP:0000260) | 1.84346472 |
| 141 | Wrist flexion contracture (HP:0001239) | 1.84164970 |
| 142 | Distal lower limb amyotrophy (HP:0008944) | 1.84034917 |
| 143 | Papilledema (HP:0001085) | 1.83307682 |
| 144 | Neonatal short-limb short stature (HP:0008921) | 1.82067904 |
| 145 | EMG: neuropathic changes (HP:0003445) | 1.80352027 |
| 146 | Abnormality of the endocardium (HP:0004306) | 1.79305535 |
| 147 | Eosinophilia (HP:0001880) | 1.79094549 |
| 148 | Abnormality of the foot musculature (HP:0001436) | 1.78940077 |
| 149 | Abnormality of the pulmonary veins (HP:0011718) | 1.77828411 |
| 150 | Aortic dissection (HP:0002647) | 1.77578533 |
| 151 | Hyperacusis (HP:0010780) | 1.77473016 |
| 152 | Bladder diverticulum (HP:0000015) | 1.76460450 |
| 153 | Neck muscle weakness (HP:0000467) | 1.75469296 |
| 154 | Shallow orbits (HP:0000586) | 1.67396367 |
| 155 | Neoplasm of the adrenal gland (HP:0100631) | 1.66811331 |
| 156 | Multiple enchondromatosis (HP:0005701) | 1.65572552 |
| 157 | Abnormality of the ischium (HP:0003174) | 1.65257821 |
| 158 | Hypoplastic left heart (HP:0004383) | 1.64890993 |
| 159 | Bicuspid aortic valve (HP:0001647) | 1.64360649 |
| 160 | Generalized muscle weakness (HP:0003324) | 1.64085843 |
| 161 | Thin bony cortex (HP:0002753) | 1.63612709 |
| 162 | Polycythemia (HP:0001901) | 1.63475733 |
| 163 | Facial diplegia (HP:0001349) | 1.63401705 |
| 164 | Rectal prolapse (HP:0002035) | 1.62949518 |
| 165 | Pheochromocytoma (HP:0002666) | 1.62154077 |
| 166 | Hypercortisolism (HP:0001578) | 1.61983242 |
| 167 | Cavernous hemangioma (HP:0001048) | 1.61546398 |
| 168 | Papilloma (HP:0012740) | 1.59892624 |
| 169 | Verrucae (HP:0200043) | 1.59892624 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.59830716 |
| 171 | Central scotoma (HP:0000603) | 1.58984318 |
| 172 | Gowers sign (HP:0003391) | 1.57513479 |
| 173 | Subacute progressive viral hepatitis (HP:0006572) | 1.57185772 |
| 174 | Mesangial abnormality (HP:0001966) | 1.57062214 |
| 175 | Patent foramen ovale (HP:0001655) | 1.56605425 |
| 176 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.54910605 |
| 177 | Hematochezia (HP:0002573) | 1.51895952 |
| 178 | Spinal rigidity (HP:0003306) | 1.51805886 |
| 179 | Double outlet right ventricle (HP:0001719) | 1.51171826 |
| 180 | Congenital malformation of the right heart (HP:0011723) | 1.51171826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 4.88803606 |
| 2 | TRIB3 | 4.71283270 |
| 3 | TTN | 4.50733675 |
| 4 | DMPK | 3.26576859 |
| 5 | LMTK2 | 3.24839923 |
| 6 | MYLK | 3.08126237 |
| 7 | TXK | 2.67993680 |
| 8 | PRPF4B | 2.64590820 |
| 9 | PHKG2 | 2.45245633 |
| 10 | PHKG1 | 2.45245633 |
| 11 | STK24 | 2.41948807 |
| 12 | TYK2 | 2.26546681 |
| 13 | MAP3K10 | 2.05057597 |
| 14 | TIE1 | 1.93570777 |
| 15 | PIK3CA | 1.89759293 |
| 16 | PDK4 | 1.80968720 |
| 17 | PDK3 | 1.80968720 |
| 18 | FES | 1.80810503 |
| 19 | ILK | 1.75957238 |
| 20 | PDGFRA | 1.75439394 |
| 21 | MAP4K1 | 1.66821159 |
| 22 | OBSCN | 1.56323271 |
| 23 | PRKD1 | 1.55288102 |
| 24 | PIK3CG | 1.49853491 |
| 25 | BTK | 1.48946467 |
| 26 | BLK | 1.46107321 |
| 27 | CDC42BPA | 1.44891959 |
| 28 | MAP3K3 | 1.38688360 |
| 29 | PAK3 | 1.38248290 |
| 30 | EEF2K | 1.36610267 |
| 31 | LRRK2 | 1.35398479 |
| 32 | RIPK4 | 1.34230448 |
| 33 | TGFBR2 | 1.31512549 |
| 34 | MAP3K7 | 1.28364942 |
| 35 | PTK6 | 1.24817568 |
| 36 | KIT | 1.24451863 |
| 37 | RIPK1 | 1.23424970 |
| 38 | IKBKE | 1.22512693 |
| 39 | TESK1 | 1.21988651 |
| 40 | FLT3 | 1.21938042 |
| 41 | SYK | 1.21151719 |
| 42 | LCK | 1.20312635 |
| 43 | NEK1 | 1.14070234 |
| 44 | ERN1 | 1.12509422 |
| 45 | SIK3 | 1.08522442 |
| 46 | ROCK1 | 1.07087646 |
| 47 | WNK4 | 1.04524574 |
| 48 | EPHB1 | 1.04112844 |
| 49 | SIK2 | 1.03194659 |
| 50 | FGFR4 | 0.99993304 |
| 51 | PRKCH | 0.99896280 |
| 52 | MAPK7 | 0.94720092 |
| 53 | PRKD2 | 0.92656404 |
| 54 | DDR2 | 0.92400009 |
| 55 | IRAK4 | 0.92086975 |
| 56 | MAP3K11 | 0.90441191 |
| 57 | MUSK | 0.89789981 |
| 58 | KDR | 0.89296676 |
| 59 | MAPK12 | 0.88696256 |
| 60 | JAK1 | 0.88523789 |
| 61 | LYN | 0.87554748 |
| 62 | TEC | 0.87000025 |
| 63 | FGFR3 | 0.86500976 |
| 64 | MAP3K13 | 0.85918561 |
| 65 | RET | 0.85222253 |
| 66 | WNK1 | 0.83972227 |
| 67 | PDK2 | 0.82699873 |
| 68 | PDGFRB | 0.82300240 |
| 69 | SIK1 | 0.81281879 |
| 70 | EPHA3 | 0.81172547 |
| 71 | STK38 | 0.80846830 |
| 72 | DAPK3 | 0.80600211 |
| 73 | STK4 | 0.79962616 |
| 74 | BCKDK | 0.79260752 |
| 75 | ITK | 0.78605307 |
| 76 | TNK2 | 0.76365709 |
| 77 | ZAP70 | 0.75627539 |
| 78 | MAP3K6 | 0.74959376 |
| 79 | TRPM7 | 0.74832100 |
| 80 | CAMK2D | 0.74612639 |
| 81 | RPS6KA2 | 0.70966554 |
| 82 | TESK2 | 0.70733673 |
| 83 | ADRBK1 | 0.69137550 |
| 84 | FYN | 0.68584149 |
| 85 | TBK1 | 0.68245803 |
| 86 | CAMK4 | 0.67595645 |
| 87 | CLK1 | 0.66162224 |
| 88 | CAMKK2 | 0.64007901 |
| 89 | INSRR | 0.63811160 |
| 90 | EPHB2 | 0.61432225 |
| 91 | MAP3K5 | 0.60186639 |
| 92 | ROCK2 | 0.59733025 |
| 93 | PRKAA1 | 0.58715005 |
| 94 | HIPK2 | 0.56785744 |
| 95 | MARK3 | 0.55350071 |
| 96 | KSR2 | 0.55308065 |
| 97 | MAP3K14 | 0.54474304 |
| 98 | GRK7 | 0.53800674 |
| 99 | PASK | 0.53529044 |
| 100 | MTOR | 0.53422387 |
| 101 | PAK2 | 0.53266094 |
| 102 | LIMK1 | 0.52404469 |
| 103 | PRKAA2 | 0.51893021 |
| 104 | TAOK1 | 0.51472659 |
| 105 | MAPKAPK3 | 0.51360580 |
| 106 | STK10 | 0.50868667 |
| 107 | JAK3 | 0.48963434 |
| 108 | DYRK1B | 0.48763926 |
| 109 | PDK1 | 0.47654845 |
| 110 | TYRO3 | 0.47311349 |
| 111 | MAP2K3 | 0.47002345 |
| 112 | CAMK1 | 0.46031044 |
| 113 | MARK2 | 0.45863014 |
| 114 | GRK5 | 0.45162477 |
| 115 | MAPK4 | 0.44479459 |
| 116 | RPS6KC1 | 0.43702925 |
| 117 | RPS6KL1 | 0.43702925 |
| 118 | PRKG2 | 0.43367408 |
| 119 | MAPK11 | 0.43054413 |
| 120 | TAOK3 | 0.42959477 |
| 121 | PRKD3 | 0.42368967 |
| 122 | ICK | 0.41109446 |
| 123 | LATS1 | 0.41063092 |
| 124 | PDPK1 | 0.40663581 |
| 125 | PTK2B | 0.40092346 |
| 126 | ALK | 0.39876921 |
| 127 | RPS6KA6 | 0.39445812 |
| 128 | TGFBR1 | 0.39062625 |
| 129 | PRKCQ | 0.39057445 |
| 130 | JAK2 | 0.36532711 |
| 131 | NLK | 0.36020135 |
| 132 | CAMK1G | 0.35961719 |
| 133 | CSK | 0.35815082 |
| 134 | UHMK1 | 0.35685988 |
| 135 | PKN1 | 0.35470261 |
| 136 | MAP3K1 | 0.34923823 |
| 137 | HCK | 0.34786478 |
| 138 | CAMKK1 | 0.32874318 |
| 139 | GRK6 | 0.31833866 |
| 140 | NEK9 | 0.31342021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.50792670 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.93552420 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.70189728 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.22277325 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.84270301 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.68860983 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.52411721 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.03195643 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00589970 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96612778 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.89051745 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77153917 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76752584 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.64670674 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64147987 |
| 16 | Focal adhesion_Homo sapiens_hsa04510 | 1.61814619 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59724672 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.58922040 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48496856 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.42683834 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.38786575 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33767611 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33167439 |
| 24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31891688 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31479057 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23268462 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.22355626 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22224768 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17653901 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13745477 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.13698260 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13406273 |
| 33 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.09990063 |
| 34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.08737122 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08697380 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08569756 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08277602 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05295717 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.02489847 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01344977 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.01241527 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01119224 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00987458 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.00536194 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00292838 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.00092437 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99997380 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99722459 |
| 49 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99645557 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99541519 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98530102 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97995801 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.97922144 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.97210321 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97150293 |
| 56 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96115726 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95799443 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.95708287 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95603910 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95517894 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.94935818 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92868504 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91652391 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91302934 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.88417487 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88153392 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88138667 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87031279 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.85149852 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83286853 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82505878 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79975487 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.79653063 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79319848 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.79082727 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78535975 |
| 77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76984913 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76797762 |
| 79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76619877 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76391650 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76366021 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76121724 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75093414 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74447129 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74358937 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74174404 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73524496 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73416881 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.73059842 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72632313 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72577789 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70585794 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.70135772 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.69888312 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68975598 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68748712 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68188717 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67640886 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.67269737 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65885806 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.65522136 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65521710 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.63925586 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63616570 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62427527 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62095757 |
| 107 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61859935 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61039713 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60567034 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59347622 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59108202 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58345585 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57998299 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57118817 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53791320 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53381930 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.53028773 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52837342 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52830696 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52771620 |
| 121 | Axon guidance_Homo sapiens_hsa04360 | 0.52335119 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51983063 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51819789 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50558044 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49917985 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49495935 |
| 127 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49476387 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48156235 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47401365 |
| 130 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46685190 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46511010 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46229170 |
| 133 | Gap junction_Homo sapiens_hsa04540 | 0.44174800 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42703420 |
| 135 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42630660 |
| 136 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41467017 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41383375 |
| 138 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41327703 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41321055 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40489825 |
| 141 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39366787 |
| 142 | Circadian entrainment_Homo sapiens_hsa04713 | 0.37740089 |
| 143 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37323160 |
| 144 | Melanogenesis_Homo sapiens_hsa04916 | 0.36717833 |
| 145 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36422564 |

